Oral contraception and congenital abnormalities

Area of Science:

• Obstetrics and Gynecology
• Perinatal Epidemiology
• Reproductive Health

Background:

• Oral contraceptive (OC) use is common among women of reproductive age.
• Understanding potential impacts of OC use on pregnancy outcomes is crucial for public health.
• Previous research has yielded mixed results regarding OC use and birth defects.

Purpose of the Study:

• To investigate the association between oral contraceptive use in the three months prior to conception and the occurrence of birth defects.
• To compare the incidence of specific congenital abnormalities between infants born to OC users and non-users.

Main Methods:

• Retrospective cohort study analyzing data from 10,479 single births in South Glamorgan.
• Categorization of mothers into 'users' (OC use within three months prior to last menstrual period) and 'non-users'.
• Comparison of the incidence of neural tube defects and other specified congenital abnormalities between the two groups.

Main Results:

• A significantly higher proportion of infants with neural tube defects were born to oral contraceptive users (27.3%) compared to non-users (72.3%).
• The incidence of abnormalities in the digestive, genito-urinary, cardiovascular systems, musculoskeletal, skin, endocrine, blood, and chromosomal systems, as well as oral clefts, showed no significant difference between users and non-users.
• Neural tube defects represented a key area of increased risk associated with recent oral contraceptive use.

Conclusions:

• Recent oral contraceptive use prior to conception may be associated with an increased risk of neural tube defects.
• Further research is warranted to elucidate the mechanisms behind this association and confirm findings.
• Current oral contraceptive use does not appear to be linked to a higher incidence of other major congenital abnormalities studied.